FDA.reportPublic FDA data

2 ML Piasky 170 MG/ML Injection

RxCUI
2686633
RxNorm name
2 ML Piasky 170 MG/ML Injection
Display name
2 ML Piasky 170 MG/ML Injection
Full name
2 ML Piasky 170 MG/ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761388Piaskycrovalimab-akkz351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PiaskyCROVALIMABGenentech, Inc.2597efc2-a97b-487c-b500-a67fd282a73b2025-11-11Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2686633

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2597efc2-a97b-487c-b500-a67fd282a73b2 ML Piasky 170 MG/ML InjectionSY3These highlights do not include all the information needed to use PIASKY safely and effectively. See full prescribing information for PIASKY. PIASKY (crovalimab-akkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202420251111
2597efc2-a97b-487c-b500-a67fd282a73bPiasky 340 MG in 2 ML InjectionPSN3These highlights do not include all the information needed to use PIASKY safely and effectively. See full prescribing information for PIASKY. PIASKY (crovalimab-akkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202420251111
2597efc2-a97b-487c-b500-a67fd282a73bPiasky 340 MG per 2 ML InjectionSY3These highlights do not include all the information needed to use PIASKY safely and effectively. See full prescribing information for PIASKY. PIASKY (crovalimab-akkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202420251111
2597efc2-a97b-487c-b500-a67fd282a73b2 ML crovalimab-akkz 170 MG/ML Injection [Piasky]SBD3These highlights do not include all the information needed to use PIASKY safely and effectively. See full prescribing information for PIASKY. PIASKY (crovalimab-akkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202420251111